Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Petrovic, Filip (57205176589)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Fatal invasive candidiasis in COVID-19 patient with severe bleeding and extensively drug-resistant Klebsiella enterobacter
    (2022)
    Adzic-Vukicevic, Tatjana (56888756300)
    ;
    Velickovic, Jelena (29567657500)
    ;
    Radovanovic-Spurnic, Aleksandra (57191847101)
    ;
    Velickovic, Dejan (14072144000)
    ;
    Milenkovic, Sara (57806830600)
    ;
    Petrovic, Filip (57205176589)
    ;
    Micic, Jelena (7005054108)
    ;
    Dragutinovic, Natasa (57211055612)
    Introduction: Multi-organ dysfunction caused by thromboembolic complications may complicate the course of SARS-CoV-2 infection. Most patients require anticoagulant therapy which predisposes them to the development of hemorrhagic syndrome. In critically ill COVID-19 patients secondary infections due to opportunistic pathogens are associated with a high mortality rate. Case report: Herein, we present a COVID-19 patient with severe hemorrhage at unusual sites complicated with invasive candidiasis and an extensively drug-resistant (XDR) strain of Klebsiella enterobacter. Conclusions: Clinicians should be aware of the possibility for invasive fungal infections in severely ill patients with SARS-CoV-2 infection due to pre-existing conditions, risk factors, and COVID-19 associated pathological mechanisms. Management of invasive candidiasis is challenging because of the high prevalence of comorbidities, risk of toxicities, and drug interactions. Copyright © 2022 Adzic-Vukicevic et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Fatal invasive candidiasis in COVID-19 patient with severe bleeding and extensively drug-resistant Klebsiella enterobacter
    (2022)
    Adzic-Vukicevic, Tatjana (56888756300)
    ;
    Velickovic, Jelena (29567657500)
    ;
    Radovanovic-Spurnic, Aleksandra (57191847101)
    ;
    Velickovic, Dejan (14072144000)
    ;
    Milenkovic, Sara (57806830600)
    ;
    Petrovic, Filip (57205176589)
    ;
    Micic, Jelena (7005054108)
    ;
    Dragutinovic, Natasa (57211055612)
    Introduction: Multi-organ dysfunction caused by thromboembolic complications may complicate the course of SARS-CoV-2 infection. Most patients require anticoagulant therapy which predisposes them to the development of hemorrhagic syndrome. In critically ill COVID-19 patients secondary infections due to opportunistic pathogens are associated with a high mortality rate. Case report: Herein, we present a COVID-19 patient with severe hemorrhage at unusual sites complicated with invasive candidiasis and an extensively drug-resistant (XDR) strain of Klebsiella enterobacter. Conclusions: Clinicians should be aware of the possibility for invasive fungal infections in severely ill patients with SARS-CoV-2 infection due to pre-existing conditions, risk factors, and COVID-19 associated pathological mechanisms. Management of invasive candidiasis is challenging because of the high prevalence of comorbidities, risk of toxicities, and drug interactions. Copyright © 2022 Adzic-Vukicevic et al.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback